Descrizione Clinica
Diagnostics - diagnostics Screen drug test urine 10
SCREEN
DRUG TESTING
URINA 10
Instructions for use for each combination of tests of the following drugs: metamfetamine methadone, amphetamine barbiturates, antidepressants fenciclidine, cocaine, marijuana, opiates, benzodiazepines.
Monophase tests for the simultaneous determination of drugs and their metabolites in human urine.
Precautions
• Product not intended for medical or diagnostic use.
• Do not use beyond expiration date.
• Store the reactive strip panel in the closed enclosure until use.
• All samples must be considered potentially dangerous and therefore must be manipulated with precautions of use relating to potentially infectious products.
• After use, the panel must be deleted according to the local rules in force.
Store in the closed enclosure at a temperature between 2° and 30°C.
The reactive strip panel is stable until the expiry date indicated on the wrapping label.
The reactive strip panel must be kept in the closed enclosure until the time of use.
Don't freeze.
Do not use it beyond the expiry date.
Expected use and summary
Screening tests for simultaneous determination of different drugs.
The rapidity and sensitivity of immunological tests have led them to be considered the most accepted as screening tests in the urine for simultaneous drug research.
The monophase test strip panel (Urina) is a lateral flow immunochromatic test for qualitative determination of the following drugs without the help of tools:
This test only provides preliminary analytical data.
More specific chemical methods must be used as confirmation of analytical result.
Preferential confirmation methods are considered for chromatography gas and mass spectrometry (GC/MS).
Any result for determining the presence of abuse drugs must be related to clinical considerations and professional judgment, especially when the preliminary result is positive.
Rapid urine screening test that does not require the use of special instruments.
The test uses antibodies to selectively detect high levels of specific substances in human urine.
Dwell times are approximate for each substance as they vary based on frequency of use, body mass, age, health status, drug tolerance, and urine pH.
The product detects the presence of narcotic substances in urine only after their metabolization.
COCAINE (COC)
Cocaine is a potent central nervous system stimulant and local anesthetic derived from the coca plant.
The substance is often self administered by inhalation or intravenous injection or by smoking the base substance.
AMFETAMINA
Amphetamine is a substance also used for therapeutic purposes.
The substance is often self- administered by inhalation or ingestion.
High doses produce enhanced stimulation of the central nervous system and induce euphoria, vigile state, appetite reduction, sense of greater energy and strength.
Acute reactions produce anxiety, paranoia, hallucinations and psychotic behavior.
METAMFETAMINA (MET/MDMA)
Metamfetamine is a powerful chemically related stimulant to amphetamine, but with a greater stimulation capacity of the central nervous system.
The substance is often self-administered by inhalation, smoking, or ingestion.
MARIJUANA (THC)
Tetrahydrocannabinol is the active ingredient in cannabis.
When smoked or taken orally, THC produces euphoria.
Regular consumers have short-term memory damage and learning delay, they can also have transient episodes of confusion and anxiety.
Relatively heavy long-term consumption may be associated with behavior disorders.
OPPIACEI (OPI)
The class of opioids refers to any substance derived from opium poppy, including natural compounds such as morphine, codeine and semisynthetic substances such as heroin.
Opiates act on pain control by depressing the central nervous system.
Astinence symptoms may include sweating, tremors, nausea and irritability.
Opiates can be taken orally or through intravenous, intramuscular and subcutaneous injection.
Consumers may also take the substance intravenously or through inhalation.
METADONE (MTD)
Metadone is a narcotic analgesic prescribed for serious to moderate pain therapy and for the treatment of opioid dependence (heroin, Vicodin, Percocet, Morfina).
Metadone is a long-acting analgesic that produces effects lasting from twelve to forty-eight hours.
BARBITURIES (BAR)
Barbiturics are used in medicine as sedatives, hypnotics and anticonvulsives.
Barbiturics are almost always taken orally in the form of capsules or tablets.
The effects resemble those of an alcohol poisoning.
Chronic use of Barbituric leads to tolerance and physical dependence.
BENZODIAZEPINE (BZO)
Benzodiazepines are frequently prescribed medicines for symptomatic treatment of anxiety and sleep disorders.
They produce their effects through specific receptors involving a neurochemical substance called aminobutyric gamma acid (GABA).
For their greater safety and effectiveness, benzodiazepines have replaced barbiturates in the treatment of anxiety and insomnia.
Benzodiazepines are also used as sedatives before surgical and medical interventions and for the treatment of epileptic attacks and alcohol withdrawal.
FENCICLIDINE (PCP)
Fenciclidine, also known as PCP or Angel Powder, is an allucinogen used in the form of powder, capsules and tablets.
The powder is inhaled or smoked after mixing it to marijuana or vegetable substances.
The PCP is commonly administered by inhalation but can also be used intravenously, intranasal and oral.
After small doses, those who make use of it think and act quickly and experience mood alterations from euphoria to depression.
Self-destructive behavior is one of the effects of PCP.
ANTIDEPRESSIVI TRICICLICI (TCA)
TCAs are commonly used for treating depressive disorders.
Overdose of TCA can cause a deep depression, cardiotoxicity and anti-linergical effects.
TCA overdose is the main cause of death from drugs.
TCAs are taken orally or sometimes by injection.
PRINCIPLE
The monophase test strip panel (Urina) is a rapid immunochromatic test based on the competitive binding principle.
Drugs that may be present in the urine sample compete with its conjugate for the same antibody binding sites.
During the test, a urine sample migrates by capillaries along the membrane.
A drug, if present in the urine sample, at a lower concentration than its cut-off, will not be able to saturate all particle binding sites related to the relative antibodies present in the strip.
Antibodies tied particles will be captured by the immobilized conjugate and a visible colored band will appear in the test band area of its strip.
The colored band will not form in its area if the drug level will be higher than its cut-off, as all related antibodies binding sites will be saturated.
A positive drug urine sample will not cause colored band formation due to drug competition, while a negative urine sample to the drug under examination or a sample containing a drug concentration lower than the cut-off will cause colored band formation in the specific test area.
As a procedure control, a colored band will appear in the relative area, indicating that a correct sample amount has been used and that the migration on the membrane occurred.
REASONS
Each strip of the panel contains monoclonal antibodies of rats linked to the particles and the corresponding.
The monophase test strip panel (Urina) is a conjugated lateral flow immunochromatic test for each drug.
Goat antibodies are used for control gang.
PRELIENT AND PREPARATION OF CHAMPIONS
Collect urine sample in a clean and dry container.
Urine samples collected at any time of the day can be used.
The urine samples with evident precipitation must be centrifuged, filtered or left to deposit so as to obtain a clear sample on which to test.
Urine samples can be stored at a temperature of 2-8°C at most for 48 hours.
For prolonged storage, samples can be frozen and stored at a temperature below -20°C.
Before using frozen samples it is necessary to make them defrost and homogenize them thoroughly.
PROCEDURE OF USE
1. Before opening the enclosure, bring it to room temperature.
Extract the product from the wrap and use it as soon as possible.
2. Remove the hood from the stripes.
Dip the product vertically, towards the arrows, into the urine sample for at least 10/15 seconds. Dip the product to the level of the undulated rows on the strips but not above them.
3. Put the cap on the device and horizontally rest the product on a flat surface not absorbent.
Read the result after 5 minutes.
Do not interpret the result after 10 minutes.
INTERPRETATION OF RESULTS
Negative*: a coloured band appears in the control area (C) and a second in the reactive area (T) for each drug indicating a negative result.
The negative result indicates that the drug concentration in the urine is below the cut-off level detectable for that specific drug.
*the color shade in the reactive zone (T) may vary, but it must be considered negative whenever a weak colored band appears.
Positive: a colored band appears in the control area (C) but not in the reactive area (T) for each drug indicating a positive result.
The positive result indicates that the drug concentration in question in urine is higher than the cut-off level detectable for that specific drug.
Not valid: the control band (C) does not appear.
The most plausible causes for the failure of the control band can be an insufficient sample volume or incorrect analytical process.
Recheck the process and repeat the test using a new panel.
If the problem persists immediately interrupt the use of the kit and contact the local distributor.
If the test was positive, avoid aggressive behaviour and calmly seek dialogue with the person concerned.
Please be advised by your doctor, a psychologist or contact the competent service for your territory.
QUALITY CONTROL
The test includes an internal control system consisting of the red band that appears in the control area (C).
The appearance of this band confirms that the test was performed correctly with a sufficient sample volume, that the absorption of the membrane was adequate and the correct procedure.
Standard controls are not provided with the kit; however it is recommended to test positive and negative controls, such as good laboratory practice, to confirm the test procedure and verify the correct characteristics.
LIMITED
The test includes an internal control system consisting of the red band that appears in the control area (C).
The appearance of this band confirms that the test was performed correctly with a sufficient sample volume, that the absorption of the membrane was adequate and the correct procedure.
Standard controls are not provided with the kit; however it is recommended to test positive and negative controls, such as good laboratory practice, to confirm the test procedure and verify the correct characteristics.
FORM
Kit containing:
• 1 urine container.
• 1 Drug Test Urina 10.
• 1 leaflet.
Monophase tests for the simultaneous determination of drugs and their metabolites in human urine.
Precautions
• Product not intended for medical or diagnostic use.
• Do not use beyond expiration date.
• Store the reactive strip panel in the closed enclosure until use.
• All samples must be considered potentially dangerous and therefore must be manipulated with precautions of use relating to potentially infectious products.
• After use, the panel must be deleted according to the local rules in force.
Store in the closed enclosure at a temperature between 2° and 30°C.
The reactive strip panel is stable until the expiry date indicated on the wrapping label.
The reactive strip panel must be kept in the closed enclosure until the time of use.
Don't freeze.
Do not use it beyond the expiry date.
Expected use and summary
Screening tests for simultaneous determination of different drugs.
The rapidity and sensitivity of immunological tests have led them to be considered the most accepted as screening tests in the urine for simultaneous drug research.
The monophase test strip panel (Urina) is a lateral flow immunochromatic test for qualitative determination of the following drugs without the help of tools:
| Test | Calibrator | Cut-off (ng/ml) |
| Metamfetamine (MET/MDMA) | D-Metamphetamine | 1.000 |
| Metadone (MTD) | Metadone | 300 |
| Amphetamine (AMP) | D-Amphetamine | 1.000 |
| Barbituric (BAR) | Secobarbital | 300 |
| Tricyclic antidepressants (TCA) | Nortriptiline | 1.000 |
| Fenciclidine (PCP) | Fenciclidine | 25 |
| Cocaine (COC) | Benzoilecgoni | 300 |
| Marijuana (THC) | 11-nor-Δ9 -THC-9 COOH | 50 |
| Opioids (OPI) | Morphine | 2.000 |
| Benzodiazepine (BZO) | Oxazepam | 300 |
This test only provides preliminary analytical data.
More specific chemical methods must be used as confirmation of analytical result.
Preferential confirmation methods are considered for chromatography gas and mass spectrometry (GC/MS).
Any result for determining the presence of abuse drugs must be related to clinical considerations and professional judgment, especially when the preliminary result is positive.
Rapid urine screening test that does not require the use of special instruments.
The test uses antibodies to selectively detect high levels of specific substances in human urine.
Dwell times are approximate for each substance as they vary based on frequency of use, body mass, age, health status, drug tolerance, and urine pH.
The product detects the presence of narcotic substances in urine only after their metabolization.
COCAINE (COC)
Cocaine is a potent central nervous system stimulant and local anesthetic derived from the coca plant.
The substance is often self administered by inhalation or intravenous injection or by smoking the base substance.
AMFETAMINA
Amphetamine is a substance also used for therapeutic purposes.
The substance is often self- administered by inhalation or ingestion.
High doses produce enhanced stimulation of the central nervous system and induce euphoria, vigile state, appetite reduction, sense of greater energy and strength.
Acute reactions produce anxiety, paranoia, hallucinations and psychotic behavior.
METAMFETAMINA (MET/MDMA)
Metamfetamine is a powerful chemically related stimulant to amphetamine, but with a greater stimulation capacity of the central nervous system.
The substance is often self-administered by inhalation, smoking, or ingestion.
MARIJUANA (THC)
Tetrahydrocannabinol is the active ingredient in cannabis.
When smoked or taken orally, THC produces euphoria.
Regular consumers have short-term memory damage and learning delay, they can also have transient episodes of confusion and anxiety.
Relatively heavy long-term consumption may be associated with behavior disorders.
OPPIACEI (OPI)
The class of opioids refers to any substance derived from opium poppy, including natural compounds such as morphine, codeine and semisynthetic substances such as heroin.
Opiates act on pain control by depressing the central nervous system.
Astinence symptoms may include sweating, tremors, nausea and irritability.
Opiates can be taken orally or through intravenous, intramuscular and subcutaneous injection.
Consumers may also take the substance intravenously or through inhalation.
METADONE (MTD)
Metadone is a narcotic analgesic prescribed for serious to moderate pain therapy and for the treatment of opioid dependence (heroin, Vicodin, Percocet, Morfina).
Metadone is a long-acting analgesic that produces effects lasting from twelve to forty-eight hours.
BARBITURIES (BAR)
Barbiturics are used in medicine as sedatives, hypnotics and anticonvulsives.
Barbiturics are almost always taken orally in the form of capsules or tablets.
The effects resemble those of an alcohol poisoning.
Chronic use of Barbituric leads to tolerance and physical dependence.
BENZODIAZEPINE (BZO)
Benzodiazepines are frequently prescribed medicines for symptomatic treatment of anxiety and sleep disorders.
They produce their effects through specific receptors involving a neurochemical substance called aminobutyric gamma acid (GABA).
For their greater safety and effectiveness, benzodiazepines have replaced barbiturates in the treatment of anxiety and insomnia.
Benzodiazepines are also used as sedatives before surgical and medical interventions and for the treatment of epileptic attacks and alcohol withdrawal.
FENCICLIDINE (PCP)
Fenciclidine, also known as PCP or Angel Powder, is an allucinogen used in the form of powder, capsules and tablets.
The powder is inhaled or smoked after mixing it to marijuana or vegetable substances.
The PCP is commonly administered by inhalation but can also be used intravenously, intranasal and oral.
After small doses, those who make use of it think and act quickly and experience mood alterations from euphoria to depression.
Self-destructive behavior is one of the effects of PCP.
ANTIDEPRESSIVI TRICICLICI (TCA)
TCAs are commonly used for treating depressive disorders.
Overdose of TCA can cause a deep depression, cardiotoxicity and anti-linergical effects.
TCA overdose is the main cause of death from drugs.
TCAs are taken orally or sometimes by injection.
PRINCIPLE
The monophase test strip panel (Urina) is a rapid immunochromatic test based on the competitive binding principle.
Drugs that may be present in the urine sample compete with its conjugate for the same antibody binding sites.
During the test, a urine sample migrates by capillaries along the membrane.
A drug, if present in the urine sample, at a lower concentration than its cut-off, will not be able to saturate all particle binding sites related to the relative antibodies present in the strip.
Antibodies tied particles will be captured by the immobilized conjugate and a visible colored band will appear in the test band area of its strip.
The colored band will not form in its area if the drug level will be higher than its cut-off, as all related antibodies binding sites will be saturated.
A positive drug urine sample will not cause colored band formation due to drug competition, while a negative urine sample to the drug under examination or a sample containing a drug concentration lower than the cut-off will cause colored band formation in the specific test area.
As a procedure control, a colored band will appear in the relative area, indicating that a correct sample amount has been used and that the migration on the membrane occurred.
REASONS
Each strip of the panel contains monoclonal antibodies of rats linked to the particles and the corresponding.
The monophase test strip panel (Urina) is a conjugated lateral flow immunochromatic test for each drug.
Goat antibodies are used for control gang.
PRELIENT AND PREPARATION OF CHAMPIONS
Collect urine sample in a clean and dry container.
Urine samples collected at any time of the day can be used.
The urine samples with evident precipitation must be centrifuged, filtered or left to deposit so as to obtain a clear sample on which to test.
Urine samples can be stored at a temperature of 2-8°C at most for 48 hours.
For prolonged storage, samples can be frozen and stored at a temperature below -20°C.
Before using frozen samples it is necessary to make them defrost and homogenize them thoroughly.
PROCEDURE OF USE
1. Before opening the enclosure, bring it to room temperature.
Extract the product from the wrap and use it as soon as possible.
2. Remove the hood from the stripes.
Dip the product vertically, towards the arrows, into the urine sample for at least 10/15 seconds. Dip the product to the level of the undulated rows on the strips but not above them.
3. Put the cap on the device and horizontally rest the product on a flat surface not absorbent.
Read the result after 5 minutes.
Do not interpret the result after 10 minutes.
INTERPRETATION OF RESULTS
Negative*: a coloured band appears in the control area (C) and a second in the reactive area (T) for each drug indicating a negative result.
The negative result indicates that the drug concentration in the urine is below the cut-off level detectable for that specific drug.
*the color shade in the reactive zone (T) may vary, but it must be considered negative whenever a weak colored band appears.
Positive: a colored band appears in the control area (C) but not in the reactive area (T) for each drug indicating a positive result.
The positive result indicates that the drug concentration in question in urine is higher than the cut-off level detectable for that specific drug.
Not valid: the control band (C) does not appear.
The most plausible causes for the failure of the control band can be an insufficient sample volume or incorrect analytical process.
Recheck the process and repeat the test using a new panel.
If the problem persists immediately interrupt the use of the kit and contact the local distributor.
If the test was positive, avoid aggressive behaviour and calmly seek dialogue with the person concerned.
Please be advised by your doctor, a psychologist or contact the competent service for your territory.
QUALITY CONTROL
The test includes an internal control system consisting of the red band that appears in the control area (C).
The appearance of this band confirms that the test was performed correctly with a sufficient sample volume, that the absorption of the membrane was adequate and the correct procedure.
Standard controls are not provided with the kit; however it is recommended to test positive and negative controls, such as good laboratory practice, to confirm the test procedure and verify the correct characteristics.
LIMITED
The test includes an internal control system consisting of the red band that appears in the control area (C).
The appearance of this band confirms that the test was performed correctly with a sufficient sample volume, that the absorption of the membrane was adequate and the correct procedure.
Standard controls are not provided with the kit; however it is recommended to test positive and negative controls, such as good laboratory practice, to confirm the test procedure and verify the correct characteristics.
FORM
Kit containing:
• 1 urine container.
• 1 Drug Test Urina 10.
• 1 leaflet.
